Incorporeal Pharma Private Limited
Founded in 2021 and headquartered in Maharashtra, India.
2021 | Sangli, Maharashtra (India) | Active
Incorporeal Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Incorporeal Pharma
Incorporeal Pharma Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 October 2021 (Three years and six months 11 days old ). Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayshri Hiremath, Sharad Patil, Aniket Sangameshwarkar, and Three other members serve as directors at the Company.
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909PN2021PTC205424
- Company No.
205424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Oct 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Trading
Other Industry
Incorporeal Pharma Private Limited
Explore comprehensive data for Incorporeal Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Incorporeal Pharma?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dineshkumar Dandekar  | Additional Director | 06-Dec-2022 | Current |
| Jayshri Hiremath | Additional Director | 27-Nov-2022 | Current |
| Sharad Patil | Additional Director | 21-Aug-2023 | Current |
| Aniket Sangameshwarkar | Director | 22-Oct-2021 | Current |
| Amit Shetti | Director | 22-Oct-2021 | Current |
| Sachin Gondhale | Director | 22-Oct-2021 | Current |
Financial Performance of Incorporeal Pharma.
Enhance accessibility to Incorporeal Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Incorporeal Pharma?
Unlock access to Incorporeal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Amogha Bio Solutions Private LimitedDineshkumar Dandekar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Incorporeal Pharma?
Incorporeal Pharma has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Incorporeal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incorporeal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Incorporeal Pharma
Recent activity within the organization
- Annual General Meeting
Incorporeal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Incorporeal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
- Director Appointment
Sharad Aannaso Patil was appointed as a Additional Director was appointed as a Additional Director on 21 Aug 2023 & has been associated with this company since 1 year 8 months .
- Director Appointment
Dineshkumar Haribhau Dandekar was appointed as a Additional Director was appointed as a Additional Director on 06 Dec 2022 & has been associated with this company since 2 years 4 months .
- Director Appointment
Jayshri Rajshekhar Hiremath was appointed as a Additional Director was appointed as a Additional Director on 27 Nov 2022 & has been associated with this company since 2 years 5 months .
- Director Appointment
Aniket Sangameshwarkar was appointed as a Director was appointed as a Director on 22 Oct 2021 & has been associated with this company since 3 years 6 months .
Frequently asked questions
What is the Incorporation or founding date of Incorporeal Pharma Private Limited?
Incorporeal Pharma Private Limited was incorporated on 22 Oct 2021.
What is authorized share capital and paid-up capital of Incorporeal Pharma Private Limited?
The authorized share capital of Incorporeal Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Incorporeal Pharma Private Limited?
Currently 6 directors are associated with Incorporeal Pharma Private Limited.
- Jayshri Rajshekhar Hiremath
- Sharad Aannaso Patil
- Aniket Sangameshwarkar
- Amit Ashok Shetti
- Sachin Bhagwant Gondhale
- Dineshkumar Haribhau Dandekar
What is the registered address of Incorporeal Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Incorporeal Pharma Private Limited is G3 Pranam Arcade Kacchi Bhavan, India, Sangli, Maharashtra, 416416.
What is the corporate identification number (CIN) and company number of Incorporeal Pharma Private Limited?
The corporate identification number (CIN) of Incorporeal Pharma Private Limited is U51909PN2021PTC205424 and the company number is 205424 as per Ministry of Corporate Affairs (MCA).
When was the last Balance Sheet of Incorporeal Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Incorporeal Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records